Retinoblastoma protein expression is an independent predictor of both radiation response and survival in muscle-invasive bladder cancer

British Journal of Cancer

Volumn 89, Issue 2, 2003, Pages 298-304

  Agerbaek, M ^a   Alsner, J ^a   Marcussen, N ^a   Lundbeck, F ^a   Von Der Maase, H ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Bladder cancer; Prognosis; Radiotherapy; Retinoblastoma protein

Indexed keywords

HEMOGLOBIN; RETINOBLASTOMA PROTEIN;

ADULT; ARTICLE; BLADDER CANCER; CANCER INVASION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; CYSTECTOMY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION RESPONSE; RADIOSENSITIVITY; STATISTICAL SIGNIFICANCE; SURVIVAL TIME; TRANSURETHRAL RESECTION; TUMOR BIOPSY; URINARY TRACT; URINE RETENTION;

ADULT; AGED; CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PHENOTYPE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETINOBLASTOMA PROTEIN; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 0042622242     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601063     Document Type: Article

References (31)

1. Fleming ID, Cooper JS, Henson DE, Hutter RV, Kennedy BJ, Murphy GP, O'Sullivan B, Sorbin LH, Yarbro JW (Eds.) (1997) AJCC Cancer Staging Manual. Philadelphia PA: Lippincott-Raven
2. Barnetson AR, Banasiak D, Fisher RJ, Mameghan H, Ribeiro JC, Brown K, Brown JL, O'Mara SM, Russell PJ (1999) Heterogeneity of in vitro radiosensitivity in human bladder cancer cells. Radiat Oncol Investig 7: 66-76
3. Bartek J, Lukas J (2001) Pathways governing G1/S transition and their response to DNA damage. FEBS Lett 490: 117-122
4. Bergkvist A, Ljungqvist A, Moberger G (1965) Classification of bladder tumours based on the cellular pattern. Preliminary report of a clinical-pathological study of 300 cases with a minimum follow-up of eight years. Acta Chir Scand 130: 371-378
5. Cheng L, Neumann RM, Weaver AL, Cheville JC, Leibovich BC, Ramnani DM, Scherer BG, Nehra A, Zincke H, Bostwick DG (2000) Grading and staging of bladder carcinoma in transurethral resection specimens. Correlation with 105 matched cystectomy specimens. Am J Clin Pathol 113: 275-279
6. Cordon-Cardo C, Wartinger D, Petrylak D, Dalbagni G, Fair WR, Fuks Z, Reuter VE (1992) Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer (see comments). J Natl Cancer Inst 84: 1251-1256
7. Cordon-Cardo C, Zhang ZF, Dalbagni G, Drobnjak M, Charytonowicz E, Hu SX, Xu HJ, Reuter VE, Benedict WF (1997) Cooperative effects of p53 and pRB alterations in primary superficial bladder tumors. Cancer Res 57: 1217-1221
8. Cote RJ, Dunn MD, Chatterjee SJ, Stein JP, Shi SR, Tran QC, Hu SX, Xu HJ, Groshen S, Taylor CR, Skinner DG, Benedict WF (1998) Elevated and absent pRb expression is associated with bladder cancer progression and has cooperative effects with p53. Cancer Res 58: 1090-1094
9. Dunst J, Sauer R, Schrott KM, Kuhn R, Wittekind C, Altendorf-Hofmann A (1994) Organ-sparing treatment of advanced bladder cancer: a 10-year experience. Int J Radiat Oncol Biol Phys 30: 261-266
10. Fossa SD, Waehre H, Aass N, Jacobsen AB, Olsen DR, Ous S (1993) Bladder cancer definitive radiation therapy of muscle-invasive bladder cancer. A retrospective analysis of 317 patients. Cancer 72: 3036-3043
11. Fung CY, Shipley WU, Young RH, Griffin PP, Convery KM, Kaufman DS, Althausen AF, Heney NM, Prout Jr GR (1991) Prognostic factors in invasive bladder carcinoma in a prospective trial of preoperative adjuvant chemotherapy and radiotherapy (see comments). J Clin Oncol 9: 1533-1542
12. Geradts J, Hu SX, Lincoln CE, Benedict WF, Xu HJ (1994) Aberrant RB gene expression in routinely processed, archival tumor tissues determined by three different anti-RB antibodies. Int J Cancer 58: 161-167
13. Gospodarowicz MK, Hawkins NV, Rawlings GA, Connolly JG, Jewett MA, Thomas GM, Herman JG, Garrett PG, Chua T, Duncan W (1989) Radical radiotherapy for muscle invasive transitional cell carcinoma of the bladder: failure analysis. J Urol 142: 1448-1453
14. Greven KM, Solin LJ, Hanks GE (1990) Prognostic factors in patients with bladder carcinoma treated with definitive irradiation. Cancer 65: 908-912
15. Grossman HB, Liebert M, Antelo M, Dinney CP, Hu SX, Palmer JL, Benedict WF (1998) p53 and RB expression predict progression in T1 bladder cancer. Clin Cancer Res 4: 829-834
16. Hoskin PJ, Saunders MI, Dische S (1999) Hypoxic radiosensitizers in radical radiotherapy for patients with bladder carcinoma: hyperbaric oxygen, misonidazole, and accelerated radiotherapy, carbogen, and nicotinamide. Cancer 86: 1322-1328
17. Jahnson S, Risberg B, Karlsson MG, Westman G, Bergstrom R, Pedersen J (1995) p53 and Rb immunostaining in locally advanced bladder cancer: relation to prognostic variables and predictive value for the local response to radical radiotherapy. Eur Urol 28: 135-142
18. Kaufman DS, Winter KA, Shipley WU, Heney NM, Chetner MP, Souhami L, Zlotecki RA, Sause WT, True LD (2000) The initial results in muscle-invading bladder cancer of RTOG 95-06: phase I/II trial of transurethral surgery plus radiation therapy with concurrent cisplatin and 5-fluorouracil followed by selective bladder preservation or cystectomy depending on the initial response. Oncologist 5: 471-476
19. Kim HL, Steinberg GD (2000) The current status of bladder preservation in the treatment of muscle invasive bladder cancer. J Urol 164: 627-632
20. Knudsen KE, Booth D, Naderi S, Sever-Chroneos Z, Fribourg AF, Hunton IC, Feramisco JR, Wang JY, Knudsen ES (2000) RB-dependent S-phase response to DNA damage. Mol Cell Biol 20: 7751-7763
21. Lipponen PK, Liukkonen TJ (1995) Reduced expression of retinoblastoma (Rb) gene protein is related to cell proliferation and prognosis in transitional-cell bladder cancer. J Cancer Res Clin Oncol 121: 44-50
22. Logothetis CJ, Xu HJ, Ro JY, Hu SX, Sahin A, Ordonez N, Benedict WF (1992) Altered expression of retinoblastoma protein and known prognostic variables in locally advanced bladder cancer (see comments). J Natl Cancer Inst 84: 1256-1261
23. Moonen L, Ong F, Gallee M, Verheij M, Horenblas S, Hart AA, Bartelink H (2001) Apoptosis, proliferation and p53, cyclin D1, and retinoblastoma gene expression in relation to radiation response in transitional cell carcinoma of the bladder. Int J Radiat Oncol Biol Phys 49: 1305-1310
24. Pagano F, Bassi P, Galetti TP, Meneghini A, Milani C, Artibani W, Garbeglio A (1991) Results of contemporary radical cystectomy for invasive bladder cancer: a clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification. J Urol 145: 45-50
25. Pollack A, Czerniak B, Zagars GK, Hu SX, Wu CS, Dinney CP, Chyle V, Benedict WF (1997a) Retinoblastoma protein expression and radiation response in muscle- invasive bladder cancer. Int J Radiat Oncol Biol Phys 39: 687-695
26. Pollack A, Wu CS, Czerniak B, Zagars GK, Benedict WF, McDonnell TJ (1997b) Abnormal bcl-2 and pRb expression are independent correlates of radiation response in muscle-invasive bladder cancer. Clin Cancer Res 3: 1823-1829
27. Rodel C, Grabenbauer GG, Kuhn R, Zorcher T, Papadopoulos T, Dunst J, Schrott KM, Sauer R (2002) Organ preservation in patients with invasive bladder cancer: initial results of an intensified protocol of transurethral surgery and radiation therapy plus concurrent cisplatin and 5-fluorouracil. Int J Radiat Oncol Biol Phys 52: 1303-1309
28. Rotterud R, Berner A, Holm R, Skovlund E, Fossa SD (2001) p53, p21 and mdm2 expression vs the response to radiotherapy in transitional cell carcinoma of the bladder. BJU Int 88: 202-208
29. Sengelov L, von der Maase H (1999) Radiotherapy in bladder cancer. Radiother Oncol 52: 1-14
30. Shelley MD, Barber J, Mason MD (2001) Surgery versus radiotherapy for muscle invasive bladder cancer (Cochrane Review). Cochrane Database Syst Rev 3: CD002079
31. Wang JY, Naderi S, Chen TT (2001) Role of retinoblastoma tumor suppressor protein in DNA damage response. Acta Oncol 40: 689-695